Cushing's syndrome trials in Netherlands

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Not yet taking people in Netherlands
  A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)

  Where

  Groningen, Leiden, Rotterdam

  Age

  18 years and over

  People

  97 worldwide

  Run by

  Crinetics Pharmaceuticals Inc.

  See details and how to join2025-522648-42-01
• No phaseEnrolling by invitation
  Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease

  Where

  Rotterdam

  Age

  18 years and over

  People

  43 worldwide

  Run by

  University Hospital, Basel, Switzerland

  See details and how to joinNCT07108244